NCT00338897 Dose Ranging Study in Elective Total Hip Replacement Surgery Status COMPLETED Phase PHASE2/PHASE3
NCT00338104 Conversion of Hyperglycemic Patients Being Treated With Intravenous Insulin Infusions to Lantus Insulin Status COMPLETED Phase PHASE4
NCT00336713 A 24-52-week Study to Evaluate the Long-term Efficacy and Safety of Saredutant in Patients With Depression (MAGENTA) Status COMPLETED Phase PHASE3
NCT00335673 I SAVE - Irbesartan in Mild to Moderate Hypertensive Patients Status COMPLETED Phase PHASE4
NCT00335595 Study of Bevacizumab Alone or Combined With Capecitabine and Oxaliplatin as Support Therapy in Metastatic Colorectal Cancer Patients Status COMPLETED Phase PHASE3
NCT00335452 Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for InterventionS Status COMPLETED Phase PHASE3
NCT00334581 Irbesartan in Chinese Hypertensive Diabetics With Microalbuminuria Status COMPLETED Phase PHASE4
NCT00332891 An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Patients With Generalized Anxiety Disorder Status COMPLETED Phase PHASE3
NCT00331994 EFESO - EFficacy Enterogermina Small Intestinal Bacterial Overgrowth Status COMPLETED Phase PHASE4
NCT00331838 Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery Status COMPLETED Phase PHASE2
NCT00327743 Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00327444 Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites Status COMPLETED Phase PHASE2/PHASE3
NCT00327171 Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian Cancer Status COMPLETED Phase PHASE2
NCT00326378 Efficacy Study of Additional Chemotherapy After Concurrent Chemoradiation in Non-small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT00325650 Rimonabant In Prediabetic Subjects To Delay Onset Of Type 2 Diabetes Status TERMINATED Phase PHASE3
NCT00325546 Study of Weight-Reducing Effect and Safety of Rimonabant In Obesity in ASIA (RIO-ASIA) Status COMPLETED Phase PHASE3